The relationship of brevetoxin ‘length’ and A-ring functionality to binding and activity in neuronal sodium channels  by Gawley, Robert E et al.
The relationship of brevetoxin ‘length’ and A-ring 
functionality to binding and activity in 
neuronal sodium channels 
Robert E Gawley l*, Kathleen S Rein*, Gerhard Jeglitsch3, 
David J Adams 3*, Emmanuel A Theodorakis4, Jorg Tiebes4, 
KC Nicolaou4 and Daniel G Baden** 
‘Department of Chemistry, University of Miami, P 0 Box 249118, Coral Gables, FL 33124, USA,*NIEHS Marine and Freshwater 
Biomedical Sciences Center, 4600 Rickenbacker Causeway, Miami, FL 33149, USA, 3Department of Molecular and Cellular 
Pharmacology, School of Medicine, P 0 Box 016189, Miami, FL 33101, USA and 4Department of Chemistry, 
Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA and Department of 
Chemistry and Biochemistry, University of California, San Diego, La Jolla CA 92093, USA 
Background: Brevetoxins are polyether ladder toxins 
that are ichthyotoxic at nanomolar concentrations.They 
bind to voltage-gated sodium channels, causing four dis- 
tinct electrophysiological effects: (i) a shift of activation 
potential; (ii) occurrence of subconductance states; (iii) 
induction of longer mean open times of the channel; 
and (iv) inhibition of channel inactivation. We set out to 
determine whether these functions all require the same 
structural elements within the brevetoxin molecules. 
Results: Several synthetically prepared structural 
analogs of brevetoxin B were examined in synaptosome 
receptor binding assays and by functional electro- 
physiological measurements. A truncated analog is not 
ichthyotoxic at micromolar concentrations, shows 
decreased receptor-binding affinity, and causes only a 
shift of activation potential without affecting mean 
open times or channel inactivation. An analog with the 
A-ring carbonyl removed binds to the receptor with 
nanomolar affinity, produces a shift of activation poten- 
tial and inhibits inactivation, but does not induce longer 
mean open times.An analog in which the A-ring diol is 
reduced shows low binding affinity, yet populates five 
subconductance states. 
Conclusions: Our data are consistent with the hypoth- 
esis that binding to sodium channels requires an elon- 
gated cigar-shaped molecule, -30 A long. The four 
electrophysiological effects of the brevetoxins are not 
produced by a single structural feature, however, since 
they can be decoupled by using modified ligands, which 
are shown here to be partial sodium channel agonists. 
We propose a detailed model for the binding of breve- 
toxins to the channel which explains the differences in 
the effects of the brevetoxin analogs.These studies also 
offer the potential for developing brevetoxin antagonists. 
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Introduction 
Brevetoxin B (PbTx-2, Fig. l), isolated from the Florida 
red tide dinoflagellate Gymnodinium breve (Ptychodiscus 
brevis) is one of several polyether ladder toxins that bind 
to the orphan receptor known as ‘site 5’ on the CL 
subunit of voltage-gated sodium channels [l]. Other 
toxins that bind at the same site, shown by displacement 
of radioactive toxin in a competitive manner, include 
PbTx-3, 5, 6, 8, and 9 (Fig. l), all of which have the 
same carbon skeleton (backbone) as PbTx-2.Two toxin 
classes with different polyether ladder backbones, breve- 
toxin A and ciguatoxin, also compete with brevetoxin B 
for binding to voltage-gated sodium channels. The 
structural similarities between these three classes of mol- 
ecules are somewhat limited: all three toxins have trans- 
fused polycyclic ring systems composed of a single 
carbon chain that winds the length of the molecule, 
with only occasional l-carbon ‘branching.’ In each toxin 
structure, the chain is linked by ether oxygens into a 
series of trans/syn fused polycyclic arrays, with ring sizes 
ranging from five- to nine-membered. 
The OL subunit of the voltage-gated sodium channel is 
thought to comprise 24 transmembrane helices grouped 
into four domains (I-Iv), each of which is divided into 
six subdomains (Sl-S6), as shown in Figure 2.A number 
of conformations of the channel protein have been iden- 
tified (or postulated), which explain the normal function 
of the channel [2-41. These conformations are grouped 
into three functionally distinct (and presumably also 
allosterically distinct) classes: open, closed, and inactivated. 
Only the open conformation is conducting, and the 
closed conformation is the resting state. After activation 
by step depolarization (closed + open), the channel nor- 
mally goes to an inactivated non-conducting state before 
returning to the closed, or resting state. A three-residue 
hydrophobic motif (Ile-Phe-Met) within a cytoplasmic 
loop of the channel polypeptide (referred to as the IFM 
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particle, see Fig. 2) is an essential structural feature of the 
channel, and may function as an inactivation lid that 
blocks ion conduction. 
When brevetoxin B binds to site 5, the physiological effect 
is a prolonged opening of the channel which is caused by 
a destabilization of the inactivated conformation of the 
protein (G. Jeglitsch, K. Rein, D.G. Baden and D.J.Adams, 
1994, Biophysical Journal, vol. 66, A323). Since the breve- 
toxins and ciguatoxin bind competitively to the same site 
of the channel, there must be some structural common 
denominator that is ‘recognized’ by the receptor site on 
the channel protein, that is, a common pharmacophore. 
Electrophysiological studies of sodium channels show four 
effects of brevetoxin B (PbTx-2 or PbTx-3): (i) a shift of 
activation potential to more negative values (channels are 
open at membrane potentials where they are normally 
closed) [5]; (ii) population of a subconductance state in 
addition to the normal conducting state (with slowed 
kinetics of ion transport) (G. Jeglitsch, et al., as above); (iii) 
induction of longer channel ‘mean open times’ ([6] and G. 
Fig. 1. Structures of the three classes of 
natural toxins that bind to site 5 of the 
voltage-gated sodium channel. The 
common features of all three toxin 
classes are summarized in the box. 
Derivatives of PbTx-2 are the K-ring 
acetate, PbTx-5, and the H-ring 
epoxide, PbTx-6. 
Jeglitsch, K., et al., as above); and (iv) inhibition of channel 
inactivation (the inactivated conformation is destabilized 
or made kinetically inaccessible) [2]. 
Based on the structure-activity relationships of several 
brevetoxin B derivatives [7] and molecular modeling of 
the brevetoxin B [8] and brevetoxin A [9] backbones 
(Fig. l), we have recently postulated that the ‘common 
pharmacophore for the toxins that bind to site 5 is a 
roughly cigar-shaped molecule, 30 A long, bound to its 
receptor primarily with hydrophobic and nonpolar sol- 
vation forces, possibly aided by strategically placed 
hydrogen bond donors near the site of the A-ring car- 
bonyls’ [9]. The notion of hydrogen bonding by the A- 
ring lactone carbonyl was derived from a comparison of 
the structures of the brevetoxin A and B backbones and 
also a comparison of the binding of PbTx-3 (brevetoxin 
B backbone, Fig. 1) with that of 2,3-dihydro PbTx-3. 
There is a seven-fold loss of binding affinity when the A- 
ring double bond is reduced, consistent with the expec- 
tation that a saturated lactone is less basic than an 
Putative brevetoxin 
binding site 
Fig. 2. Cartoon representing the sec- 
ondary structure of the a-subunit of the 
voltage-gated sodium channel. The 
subunit comprises four homologous 
domains and six subdomains, with 
intracellular and extracellular loops. 
The position of the IFM particle, which 
is thought to be involved in inactiva- 
tion of the open channel, is shown. 
Amino-acid residues forming the IFM 
particle are represented by 0. A 
protein kinase C phosphorylation site 
is indicated by 0. 
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ol,@unsaturated lactone, making it a poorer hydrogen 
bond acceptor [7]. 
To further test the common pharmacophore hypothesis, 
we have prepared by total synthesis or degradation three 
brevetoxin derivatives (Fig. 3) for bioasssay.These include 
a ‘truncated’ brevetoxin B (compound 1) [lo], that has all 
the functionality of brevetoxin B but is 10 A shorter, a 
brevetoxin PbTx-3 derivative lacking the A-ring car- 
bony1 oxygen, (compound 2), and the 2,3-dihydro A- 
ring-reduced diol, (compound 3), reported previously 
[7]. We report here the results of the testing of these 
analogs in synaptosome binding and electrophysiological 
studies, which provide strong support for the pharma- 
cophore hypothesis stated above. We also o&r an 
extended hypothesis to explain the mechanism for the 
observed inhibition of sodium channel inactivation 
induced by brevetoxins. 
Results and discussion 
Synaptosome binding by brevetoxin and analogs 
The binding affinities of the three analogs described 
above to synaptosomes were determined using a compe- 
tition assay (Table 1). Three native brevetoxins were also 
examined. Of the analogs, only the 1-desoxy PbTx-3 
displaces tritiated brevetoxin in a competitive fashion, 
with 50 % inhibition at nanomolar concentrations. The 
other analogs fail to displace tritiated PbTx-3, even at 
micromolar concentrations. The loss of the A-ring 
oxygen (compare PbTx-3, Fig. 1 to 1-desoxy PbTx-3, 
Fig. 3. Brevetoxin 6 derivatives used in 
this study. 
Table 1. Synaptosome binding data for native brevetoxins and 
PbTx-1 4.4 2.9-3.4 
PbTx-2 15.02 6.36-7.93 
PbTx-3 8.48 6.09-l 1.81 
1 >10 000 
2 36.5 26.8-49.6 
3 >25 OOOb - 
aMeasured against 1.8 nM L3H]-PbTx-3. Values for native tox- 
ins differ slightly from those published previously since we 
now use a different curve-fitting program to process the data. 
bData taken from 181. 
compound 2, Fig. 3) results in a seven-fold loss in 
binding afEnity, which is qualitatively consistent with the 
presence of a hydrogen bond donor in the vicinity of the 
A-ring lactone carbonyl, as stated in the pharmacophore 
hypothesis above. Quantitative interpretation is not pos- 
sible, since the differences between a methylene and a 
carbonyl group also include differences in steric require- 
ments, electrostatics, and dipoles; however, interesting 
differences in the electrophysiological effects of the com- 
pounds are observed and are discussed below. 
Particularly intriguing is the inability to displace tritiated 
PbTx-3 with the shorter analog, truncated PbTx-2 (com- 
pound l), which has a very similar structure, including all 
Truncated PbTx-2, 1 
1 -Desoxy PbTx-3, 2 
2,3-Dihydro PbTx-3 A-ring diol, 3 
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the functional groups of PbTx-2, the same absolute con- 
figuration, and very similar hydrophobicity. We also find 
that the truncated PbTx-2 is not toxic to mosquito fish 
(Gambtrsia u#;nis) at PM concentrations, whereas PbTx-2 
has an LC,, of 14 nM [7]. When compared to the global 
minimum conformation of PbTx-2 [8,9], compound 1 is 
10 A shorter. Figure 4 shows a Corey-Pauling-Koltun 
(CPK) model of the PbTx-2 backbone in its lowest 
energy conformation and a CPK model of the truncated 
backbone of compound 1. Figure 5 shows displacement 
curves from the synaptosome binding assay for com- 
pounds 1 and 2, with PbTx-3 included for comparison. 
(PbTx-2 and PbTx-3 have different side chains at the tail 
end of the molecule, but we have already shown that these 
differences have a negligible effect on binding affinity [7]). 
Examination of the two CPK models in Figure 4 does not 
reveal any obvious structural features that could account for 
the dramatic difference in the binding a5nity of PbTx-3 
and compound 2. Truncated PbTx-2 differs from PbTx-2 
in two ways however: the overall length of the molecule is 
reduced, and the flexibility normally endowed on the mol- 
ecule by the two seven-membered rings (D and E of 
PbTx-2, Fig. 1) is missing. Molecular modeling studies 
[8,9] have shown that the eight-membered H-ring of the 
brevetoxin B backbone is locked into a boat-chair confor- 
mation by the torsional constraint of the double bond. 
Thus, the eight-membered rings of both PbTx-2 and the 
truncated analog 1 are rigid. Reduction of this double 
bond changes the global minimum to a crown conforma- 
tion, resulting in a -lOOO-fold loss in binding affinity [7]. 
Because all the six-membered rings of the brevetoxin B 
backbone are rigid by virtue of their truns-decalin-like 
nature, the only conformational motion available is at the 
seven-membered D and E rings. This structural feature is 
removed in the truncated analog 1 (Fig. 3). 
A comparison of the low-energy minima of both the 
brevetoxin A and B backbones, and consideration of the 
fact that both ligands bind competitively to the same 
receptor, led us to conclude that the conformation of 
Fig. 4. Computer-rendered CPK models of truncated PbTx-2 
(compound 1) (top) and PbTx-2 (bottom), oriented with the 
‘head’ of the toxin (see Fig. 1) to the left. The side chain at the 
‘tail’ of the molecules has been replaced by a methyl group. 
al 
-3 -2 
Lo; comtetitor doncent2ration ;nM) 
4 5 
Fig. 5. Compound 1 binds to receptor less well than PbTx-3 or 
compound 2. Displacement of 1.8 nM tritiated PbTx-3 with 
unlabeled PbTx-3 (W), unlabeled compound 1 (0) or unlabeled 
compound 2 (A) is shown as curves of percent of maximum 
binding versus log of competitor concentration. 
brevetoxin B, when bound to site 5, is straight (as opposed 
to some possible conformations that have a significant bend 
at the seven-membered D/E rings) 193 .Truncated PbTx-2 
has a shape that is similar to the lowest energy linear con- 
formation of the brevetoxin B backbone (Fig. 4). If our 
conclusions about the conformation of brevetoxins bound 
to site 5 are correct, then the only difference that can 
account for lack of binding is the length of the toxin. 
Electrophysiological effects of brevetoxin and analogs 
We next determined the effects of PbTx-3 and truncated 
PbTx-2 (compound 1) on depolarization-activated single- 
sodium-channel currents (Fig. 6). There are two structural 
differences between these molecules: the truncation and 
the K-ring side chain (PbTx-2 is an aldehyde and PbTx-3 
is an alcohol). However, at concentrations of 30-500 nM, 
PbTx-2 and PbTx-3 are indistinguishable electrophysio- 
logically (data not shown). PbTx-3 clearly has profound 
effects on channel opening at 30 and 500 nM concentra- 
tions, whereas truncated PbTx-2 (1) shows very little 
effect even at 1 PM concentration. 
The mean open times of single sodium channels in the 
absence (control) or presence of 30 nM PbTx-3 or 
10 PM truncated PbTx-2 are shown in Fig. 7a. In the 
absence of added ligand (control), the channel activates at 
-40 mV, whereas in the presence of either PbTx-3 or 
truncated PbTx-2, the channel activates at -50 mV (i.e., 
both compounds produce a negative shift of 10 mV in the 
activation potential). Channel openings are also observed 
at the resting membrane potential (-50 mv). The mean 
channel open times in the presence of 30 nM PbTx-3 are 
increased significantly compared to control conditions. 
The mean channel open times in the presence of trun- 
cated PbTx-2 (l), at similar concentrations, are nearly the 
same as the control. Even at 10 PM concentrations (a 
333-fold increase), the effect of truncated PbTx-2 is small 
at potentials more negative than -30 mV. Figure 7b shows 
the effect of ligand concentration on mean open times at 
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Fig. 6. Depolarization-activated single 
sodium channel currents in the absence 
(control) or presence of (a) 30 and 500 
nM PbTx-3, and (b) 1 and 70 pM trun- 
cated PbTx-2 (compound 1). Typical 
consecutive traces (100 ms) of unitary 
sodium currents (downward deflections) 
obtained upon depolarization lo 
-40 mV and -10 mV from -100 mV in 
(a), and to -30 mV from -100 mV in (b). 
Measured resting membrane potential 
(RMP) = -50 mV. The voltage protocol 
is shown above. Pipette and bath solu- 
tions are described in Materials and 
methods. 
(a) 
(b) 
c!antral 
-40mV * 
-10 mV 
30 IIM PbTx-3 
40mv M 
-10 mV 
500 nM PbTk-3 
-4OmV ] 
-10 mV 
10 pA 
4oms 
-30 
-50 
-100 contd 
1 pMTruncakd PbTk-2 
10 j,~MTnmcakd PbTx-2 
selected potentials. Here again, note that the truncated 
toxin has negligible effect compared to PbTx-3 at poten- 
tials from -40 to 0 mYTruncated PbTx-2 is not ichthy- 
otoxic; of the four characteristics of native brevetoxins 
mentioned above, it does not possess the binding affinity 
of a native toxin, and it does not prolong mean open times 
or inhibit inactivation, although it does shit? the activation 
potential. It may therefore be considered to be a partial 
brevetoxin agonist. 
Steady-state recordings of channel openings in the pres- 
ence of 500 nM PbTx-3 and 1 PM I-desoxy PbTx-3 
(compound 2) are shown in Figure 8. Under control 
conditions, the channel briefly opens following depolar- 
ization, then becomes inactivated. If the depolarizing 
potential is maintained, the channel will remain in the 
inactivated conformation until the membrane is hyper- 
polarized, at which point the conformation moves fEom 
the inactivated to the closed state. In the presence of 
500 nM PbTx-3 (Fig. Ba), channels open and tend to 
remain open. In the presence of I-desoxy PbTx-3 at 
twice the concentration (1 PM, Fig. Bb), the channels 
exhibit only brief open times, but repeatedly open (and 
close) over the entire sampling time (unmodified channels 
open only once) .This observation is all the more surpris- 
ing since the only difference between the two ligands is 
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Fig. 7. Effects of PbTx-3 and truncated PbTx-2 on channel opening. (a) The mean channel open time (Q-J obtained at different mem- 
brane potentials in the absence of ligand (0) or presence of 30 nM PbTx-3 (W) or 10 PM truncated PbTx-2 (A.). Each data point repre- 
sents mean f one standard error of the mean 70 calculated from at least three experiments. (b) The mean channel open time as a 
function of ligand concentration for PbTx-3 and compound 1 (‘truncated’) at -40, -20, and 0 mV membrane potential. 
the presence or absence of the carbonyl oxygen in the A- The A-ring diol (compound 3) [7], under steady-state 
ring lactone. Regarding the four characteristics of native conditions at 10 FM concentration, induces the channels 
brevetoxins mentioned above, 1 -desoxy PbTx-3 (com- to populate five subconductance states (Fig. 9). 
pound 2) clearly does not induce longer mean open Subconductance states are, by definition, ion-conducting 
times, although it does shift the activation potential and conformations of the channel in which the rate of sodium 
inhibit inactivation. Compound 2 therefore may also be ion transport differs from the 21 pS fully open channe1.A 
considered to be a partial brevetoxin agonist. conductance substate arises whenever a channel occupies a 
(a) \In= 40 mV 
500 nM wlk-3 
10 
20 
30 
W lph4 l-Deisoxy PbTk-3 
10 
-l 
3pA 
mma 
Fig. 8. Steady-state recordings of single 
sodium channel openings in the pres- 
ence of (a) 500 nM PbTx-3 or (b) 1 )LM 
compound 2. The membrane potential 
was held constant at -40 mV over a 
period of 1 min. 200 ms current traces, 
obtained after 10, 20, 30, and 40 s are 
shown for each compound. 
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Fig. 9. Steady-state recordings of 
single sodium channel openings in the 
presence of 10 )LM compound 3. The 
membrane potential was held at 
-40 mV. Examples of different subcon- 
ductance levels (I-V) and the closed 
state (C) are shown. 
10 PM 2,3-Dihydro-PbTx-3 A-ring diol 
V. = -40 mV 
2.5 pA 
I 
30 ms 
conformational state with an energy profile for ion per- 
meation that is different from the energy profile for the 
main conductance state. Under control conditions, during 
single-channel recordings, most openings are to the main 
conductance state (V), but subconductances are seen when 
the channel visits other less favorable conformations [ 111. 
In the case of toxin interaction with channels, the toxin 
stabilizes these less favorable channel conformations, 
allowing the subconductance states to be observed. 
In summary, experiments that measure specific binding to 
synaptosomes and single sodium channel currents indi- 
cate a substantial loss of binding and significantly modi- 
fied activity when the brevetoxin B backbone is 
shortened by 10 A (truncated PbTx-2 (1)). Removal of 
the A-ring carbonyl oxygen (desoxy PbTx-3 (2)) results 
in a seven-fold decrease in binding and a loss of the 
ability to prolong the channel open time. Reduction of 
the A-ring to a saturated diol induces a significant loss of 
binding affinity [7], while affording a ligand capable of 
populating five channel subconductance states. 
These observations are consistent with the common 
pharmacophore hypothesis stated above [9].We now wish 
to extend this hypothesis to include a model of how the 
toxin binds to the channel and affects conformational 
motion (Fig. 10). Because the truncated toxin (compound 
1) shows a low binding affinity and does not alter sodium 
channel kinetics, but still produces a shift of the activation 
potential, we conclude that the ‘cigar shape’ may be all 
that is necessary to induce this last effect. Furthermore, 
we know from photoaffinity studies that the ‘tail’ of the 
brevetoxin B backbone resides in the vicinity of the 
S5-S6 extracellular loop of domain IV of the protein (see 
Fig. 2) [12,13]. Based on the fact that compounds in 
which the A-ring is modified show altered kinetics of 
inactivation and population of subconductance states, we 
believe that the ‘head’ of the toxin is in the vicinity of the 
IFM particle (III,,-IV,, intracellular loop, see Fig. 2) on 
the cytoplasmic side of the membrane. 
It remains to be determined precisely where the breve- 
toxin molecule lies with respect to the various helices 
Fig. 10. Hypothetical model of the 
binding of brevetoxin to site 5 of the 
voltage-gated sodium channel, with the 
tail of the model near the Is5-s6 loop and 
the head near the inactivation particle. 
The cartoon of the channel protein is 
based on that in [4]. 
Domain III IIIS5-S6 
Domain IV, 
Brevetoxi n 
‘tail’ 
‘head’ 
IFM particle I 
Domain I 
Position of IFM, 
Domain II 
IIs a-helix 
‘inactivated’ 
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and domains of the voltage-sensitive sodium channel, but 
from these results in the context of earlier work it is clear 
that the orientation is ‘head down’ near the interface of 
domains I and IV of the channel. 
Significance 
Brevetoxins are neurotoxins that pose a signifi- 
cant health risk because of their neurotoxic 
effects, as manifested in neurotoxic shellfish poi- 
soning. Brevetoxins and ciguatoxin bind in a 1:l 
stoichiometry to a unique site on the channel 
protein OL subunit known as site 5, with IC,, 
values in the nanomolar range. The common 
pharmacophore of the brevetoxins is thought to 
be a 30-A long cigar-shaped molecule that binds 
to the protein primarily by hydrophobic inter- 
actions, but hydrogen bonding to the A-ring 
carbonyl seems to be important as well. 
The voltage-gated sodium channel opens follow- 
ing depolarization; the open channel is thought 
to be inactivated by movement of a segment of 
one of the intracellular loops, the IFM particle, 
to block the channel. We propose a model in 
which the toxin binds to an open (conducting) 
conformation of the channel protein and the 
head of the toxin physically obstructs the normal 
motion of the IFM particle, directly or indirectly 
(much as a pencil might be used to stop a door 
from closing). This model accounts for all the 
known facts regarding brevetoxin toxicity, partic- 
ularly the kinetic inaccessibility of the ‘inacti- 
vated’ conformations. Finally, the C-l carbonyl 
oxygen is now explicitly implicated in the pro- 
longing of ‘mean open times’, probably through 
hydrogen bonding. 
The structure-activity relationships derived from 
the analogs studied here indicate clearly that the 
four properties of the brevetoxins are not pro- 
duced by a single structural feature, since they 
can be ‘decoupled’ in modified ligands. This 
implies that brevetoxin derivatives can be pro- 
duced which are partial sodium channel ago- 
nists, and further that it is distinctly possible 
that brevetoxin antagonists could be developed. 
Materials and methods 
Synthesis 
Details for the synthesis of truncated PbTx-2, (1) [lo], and 
diol 3 [7] have been published. 1-Desoxy PbTx-3, compound 
2, was prepared in two (unoptimized) steps from PbTx-3: 1) 
sodium borohydride reduction to the A-ring diol having the 
2,3-double bond intact, as described previously [7]; 2) 
Mitsunobu cyclization [14,15]: the A-ring diol (6.0 mg, 6.67 
x 10m3 mmol) was dissolved in 10 ml ether (distilled from 
sodium benzophenone). To this solution was added Ph,P 
(5.35 mg, 2.04 x 10W2 mmol), followed by diethylazodicar- 
boxylate in ether (10 ~1, 181 mg r&l). After stirring at room 
temperature for 4 days, the reaction mixture was partitioned 
between ether and water. The organic phase was condensed, 
then taken up in 2 ml MeOH and purified by reversed phase 
high-pressure liquid chromatography (HPLC) (C,, column, 
85 % aq. MeOH eluent). Concentration of the eluate 
afforded 0.740 mg (12 %) of compound 2. High-resolution 
mass spectrometry (fast atom bombardment, nitrobenzyl 
alcohol (NBA) matrix) MH+ calc’d. for C,,H,,O,, 
883.5207, found 883.5198. The ‘H NMR (400 MHz) 
showed the following diagnostic peaks: 65.35 (lH, bs, C-2 
vinyl proton), 4.25-4.16 (2H, broadened AB quartet, buried 
under other allylic ether signals). 
Synaptosome binding 
Synaptosomes were prepared by the method of Dodd et al. 
[16] from male Sprague-Dawley rats (200-250 g). Total 
binding was measured using a rapid centrifugation technique 
described previously [17]. Non-specific binding was mea- 
sured in identical incubation tubes by adding 10 p,M unla- 
beled PbTx-3 to completely displace all specifically bound 
radioactive toxin (radioactivity that cannot be displaced by 
excess ligand is non-specific [18]). All binding experiments 
were performed in standard binding medium (SBM) consist- 
ing of 50 mM HEPES (pH 7.4), 130 mM choline chloride, 
5.5 mM glucose, 0.8 mM magnesium sulfate, 5.4 mM potas- 
sium chloride, 1 mg ml-’ bovine serum albumin, and 0.01 % 
Emulphor EL-620, a non-ionic detergent used as an emulsi- 
fier. The latter was required to solubilize the high concentra- 
tion of competitor toxins. A suspension of synaptosomes 
(40-80 pg total protein in 100 ~1 SBM) was added to 
microfuge tubes containing t3H]PbTx-3 (1.78 nM) and com- 
petitor (12 different concentrations in the range 
0.1 nM-10 p.M) for a total final volume of 1.0 ml. After 
mixing and incubating at 4 “C for 1 h, the tubes were cen- 
trifuged for 3 min at 15 000 x g. Supernatant solutions were 
aspirated and the remaining pellet rapidly rinsed with 0.5 ml 
of cold (0 “C) SBM. The pellets were transferred to liquid 
scintillation vials and bound radioactivity was counted on a 
Beckman LS 1801 liquid scintillation counter in 3.0 ml of 
Ecolume (ICN Biomedicals, Costa Mesa, CA). IC,, data were 
obtained by fitting a one site competition curve to displace- 
ment data using the program Prism (v 1.0, GraphPad, Inc.). 
Binding was determined to be competitive using the method 
of Cheng and Prusoff [ 191. 
Electrophysiology: 1. Cell preparation 
The mammalian nodose ganglion is a visceral afferent sensory 
ganglion which is located along the vagus nerve at the level of 
the bifurcation of the carotid arteries.The nodose ganglia were 
dissected from newborn rats (l-2 weeks old), killed by 
intraperitoneal injection of sodium pentobarbital. The ganglia 
were removed, transferred into Krebs-Anger solution and 
cleaned of connective tissue. The isolated ganglia were pinned 
out and digested with collagenase (0.6 mg ml-l, Wothington 
Type) and protease (0.4 mg ml-‘, Sigma). After 1 h at 37 “C 
the ganglia were transferred to a sterile culture medium 
(Dulbecco’s modified Eagle medium, 10 % (v/v) fetal calf 
serum, 100 U ml-’ penicillin, 0.1 mg ml-l streptomycin) and 
also mechanically dissociated using forceps.The tissue fragments 
were triturated with a sterile fine-bore Pasteur pipette.The dis- 
sociated neurons were plated onto laminin-coated 18 mm glass 
coverslips, placed in a 35 x 10 mm plastic culture dish (Falcon) 
and incubated at 37 “C in a 95 % air, 5 % CO, atmosphere.The 
neurons were placed in tissue culture 48-72 h prior to use. All 
neurons had a diameter between 15 pm and 25 pm. 
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II. Solutions 
The composition of the physiological salt solution was (mM): 
140 NaCl, 3 KCl, 0.6 MgCl,, 2.5 CaCl,, 7.7 glucose, 10 histi- 
dine, pH = 7.4. The extracellular solution for single-channel 
recordings contained (mM): 140 NaCl, 3 KCl, 1 CaCl*, 0.6 
MgCl, 7.7 glucose, 10 HEPES, adjusted to pH 7.4 with NaOH. 
The pipette solution for single-channel recordings contained 
(n&I) 140 NaCl, 3 KCl, 0.6 MgCl,, 2.5 BaC&, 30 tetraethylam- 
monium chloride (TEACl), 7.7 glucose, 0.1 4,4’-diiothio- 
cyanato-2,2’-stilbene disulfonic acid salt (DIDS), 10 HEPES, and 
was adjusted to pH 7.4 with NaOH. For single-channel record- 
ings in the presence of toxin, either tetrodotoxin (TTX), PbTx- 
3, or one of the derivatives was added to the patch pipette 
solution at the concentrations stated.TTX was dissolved in dis- 
tilled water, brevetoxins and analogs in absolute EtOH. 
Experiments were conducted at room temperature (22-23 “C). 
III. Electrophysiological recording 
Single-sodium-channel currents were recorded from cell- 
attached membrane patches using the patch clamp technique 
[20]. Patch pipettes were pulled from thick-walled borosilicate 
glass (GC150E Clark Electromedical Inst., UK). The tip was 
fire-polished on a microforge and coated with Sylgard (Dow 
Corning) to reduce electrode capacitance. Pipettes had tip resis- 
tances of lo-15 Ma when filled with pipette solution. Patch 
electrodes were sealed against the membrane by suction, leading 
to seal resistances between 5-10 Gfi.Voltage steps were applied 
to the patch pipette with pulse protocols generated by a com- 
puter (PC 486D/50 MHz) and pClamp programs (Axon 
Instruments, Inc., CA). The membrane potential was initially 
held at -100 mV (the measured resting membrane potential was 
- -50 mV) before depolarizing voltage steps were applied. 
Single-channel currents were recorded using an Axopatch 200A 
patch clamp amplifier (Axon Instruments), filtered at 2 kHz (-3 
dB, 4-pole low pass Bessel filter) and sampled at 10 kHz with an 
A/D converter (TL-1 Labmaster DMA interface) and com- 
puter using pClamp programs. Linear leak and capacitative cur- 
rents were subtracted from current traces using records which 
contained no openings during the depolarizing (200 ms) pulse. 
Steady-state single-channel currents were recorded on video- 
tape using an A/D recorder adapter (PCM-2, Medical Systems, 
NY) prior to computer analysis. All data were analyzed by using 
pClamp version 5.5.1 and Filecut version 2.1. Numerical data 
are represented as the mean ? one standard error of the mean. 
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